Crystalline forms of an antiviral benzimidazole compound

Details Crystalline forms of an antiviral benzimidazole compound Crystalline forms of an antiviral benzimidazole compound

2007-11-20

2007-11-20

Jiang, Shaojia Anna (Department: 1623)

Drug, bio-affecting and body treating compositions

Designated organic active ingredient containing

Carbohydrate doai

C536S028900

Reexamination Certificate

active

10007272

ABSTRACT:
The invention relates to Form physical forms of 5,6-dichloro-2-(isopropylamino)-1-β-L-ribofuranosyl-1H-benzimidazole, pharmaceutical compositions comprising the same, and their use in medical therapy.

REFERENCES:
patent: 3399987 (1968-09-01), Woods et al.
patent: 3555040 (1971-01-01), Frick et al.
patent: 3655901 (1972-04-01), Jensen et al.
patent: 5248672 (1993-09-01), Townsend et al.
patent: 5360795 (1994-11-01), Townsend et al.
patent: 5473063 (1995-12-01), Classon et al.
patent: 5574058 (1996-11-01), Townsend et al.
patent: 5646125 (1997-07-01), Townsend et al.
patent: 5654283 (1997-08-01), Townsend et al.
patent: 5665709 (1997-09-01), Townsend et al.
patent: 5998605 (1999-12-01), Chamberlain et al.
patent: 6077832 (2000-06-01), Chamberlain et al.
patent: 6307043 (2001-10-01), Chamberlain et al.
patent: 6469160 (2002-10-01), Glover et al.
patent: WO 9207867 (1992-05-01), None
patent: WO 9408456 (1994-04-01), None
patent: WO 9601833 (1996-01-01), None
patent: WO 9725337 (1997-07-01), None
patent: WO 9951617 (1999-10-01), None
Graul, A., et al., “1263W94 Antiviral”,Drugs of the Future, vol. 22, No. 7, pp. 707-710 (1997).
Gordon, Irving, et al., “Kinetics of Decay in the Expression of Interferon-Dependent MRNAs Responsible for Resistance to Virus”,Proc. National Academy Sciences USA, vol. 77, No. 1, pp. 452-456. (Jan. 1980).
Devivar, Rodrigo V., et al., “Benzimidazole Ribonucleosides: Observation of an Unexpected Nitration when Performing Non-Aqueous Diazotizations with t-butyl Nitrite,”Bioorganic&Medicinal Chemistry Letters, vol. 2, No. 9, pp. 1105-1110.(Sep. 1992).
Tigges, Michael A., et al., “Human CD8+ Herpes Simplex Virus-Specific Cytotoxic T-Lymphocyte Clones Recognize Diverse Viron Protein Antigens”,Journal of Virology, vol. 66, No. 3, 1622-34. (Mar. 1992).
Devivar, Rodrigo V., et al., “Benzimidazole Ribonucleosides: Design, Synthesis, and Antiviral Activity of Certain 2-(Alkylthio)-and 2-(benzylthio)-5,6-dichloro-1-(B-D-ribofutanosyl) benzimidazoles”,Journal of Medicinal Chemistry, vol. 37, No. 18, pp. 2942-2949 (Sep. 2, 1994).
Townsend, Leroy B., et al., “Design, Synthesis, and Antiviral Activity Activity of Certain 2,5,6-Trihalo-1-(B-D-ribofuranosyl)benzimidazoles”,Journal of Medical Chemistry, vol. 38, No. 20, 4098-4105 (Sep. 25, 1995).
Yankulov, Krassimir, et al., The Transcriptional Elongation Inhibor 5,6-Dichloro-1-B-D-ribofuranosylbenzimidazole Inhibits Translation Factor IIH-Associated Protein Kinase,Journal of Biological Chemistry, vol. 270, No. 41, pp. 23922-23925.(Oct. 13, 1995).
Nassiri, M. Reza, et al., “Comparison of Benzimidazole Nucleosides and Ganciclovir on the In Vitro Proliferation and Colony Formation of Human Bone Marrow Progenitor Cells,”British Journal of Haematology, vol. 93, No. 2, pp. 273-279. (May 1996).
Gudmundsson, Kristjan S., et al., “Synthesis and Antiviral Activity of Certain 5′-Modified Analogs of 2,5,6-Trichloro-1-(B-D-ribofuranosyl) benzimidazole,”Journal of Medicinal Chemistry, vol. 40, No. 5, pp. 785-793 (Feb. 28, 1997).
Fessenden, Ralph J., et al., “Crystallization”,Organic Laboratory Techniques, 3rdedition, Brooks/Cole (Canada), (2001), only preface and pp. 23-38.
Fieser, Louis D., et al., “Crystallization”,Organic Experiments, DC Heath and Company, Boston, MA, (1964), only preface and pp. 41-51.
Zou, Ruiming, et al., “Design, Synthesis, and Antiviral Evaluation of 2-Chloro-5-6,dihalo-1-(B-D-ribofuranosyl) benzimidazoles as Potential Agents for Human Cytomegalovirus Infections”,Journal of Medicinal Chemistry, vol. 40, No. 5, (1997), pp. 811-818. (Feb. 28, 1997).

Affiliated with

Also associated with

Rating

Crystalline forms of an antiviral benzimidazole compound does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Crystalline forms of an antiviral benzimidazole compound, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Crystalline forms of an antiviral benzimidazole compound will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-3832708